PHLPP2 (766-1043), homme BST étiqueté, recombinant, exprimé en E. coli, > = 70 % (SDS - PAGE) , solution de glycérol aqueux TAMPONNÉE

Code: srp5213-50ug D2-231

Non disponible en dehors du Royaume-Uni et de l'Irlande

General description

PHLPP2 or PH domain and leucine rich repeat protein phosphatase 2 is the important regulators of Akt serine-threonine kinases and conventional/novel prote...


en savoir plus

Votre prix
$380.68 50UG

Non disponible en dehors du Royaume-Uni et de l'Irlande

General description

PHLPP2 or PH domain and leucine rich repeat protein phosphatase 2 is the important regulators of Akt serine-threonine kinases and conventional/novel protein kinase C (PKC) isoforms. PHLPP1 and PHLPP2 differentially regulated AKT signaling by selectively dephosphorylating the hydrophobic motifs of AKT2 or AKT3. PHLPP may act as a tumor suppressor in several types of cancer due to its ability to block growth factor-induced signaling in cancer cells.

Physical form

Supplied in 50mM Tris-HCl, pH 7.5, 150mM NaCl, 10mM glutathione, 0.1mM EDTA, 0.25mM DTT, 0.1mM PMSF, 25% glycerol.

Preparation Note

after opening, aliquot into smaller quantities and store at -70 °C. Avoid repeating handling and multiple freeze/thaw cycles

assay≥70% (SDS-PAGE)
biological sourcehuman
formbuffered aqueous glycerol solution
Gene Informationhuman ... PHLPP2(23035)
mol wt~56 kDa
NCBI accession no.NM_015020
recombinantexpressed in E. coli
shipped indry ice
storage temp.−70°C
Ce produit répond aux critères suivants: